Dapagliflozin Combined With Next-generation Hormonal Agent (NHA) Versus Single NHA in Participants With Metastatic Castrate-resistant Prostate Cancer
Clinical trial NCT07310433 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07310433
- Sponsor
- Yung NA
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2029-10-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.